Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
Glioblastoma (GBM) is the most common aggressive malignant tumor in brain neuroepithelial tumors and remains incurable. A variety of treatment options are currently being explored to improve patient survival, including small molecule inhibitors, viral therapies, cancer vaccines, and monoclonal antib...
Saved in:
Main Authors: | Hui Liu (Author), Weimin Qiu (Author), Tianyu Sun (Author), Lei Wang (Author), Chenxi Du (Author), Yanyu Hu (Author), Wenyuan Liu (Author), Feng Feng (Author), Yao Chen (Author), Haopeng Sun (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Passing across the blood-brain barrier in glioblastoma multiforme (GBM)
by: Agata Rocka, et al.
Published: (2020) -
Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches
by: Liya Feng, et al.
Published: (2024) -
Small molecule KDM4s inhibitors as anti-cancer agents
by: Hongzhi Lin, et al.
Published: (2018) -
Minutes of GBM held at Gandhinagar
Published: (2016) -
Anti-GBM Disease in Pregnancy
by: Mohammed Muqeet Adnan MD, et al.
Published: (2015)